AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.8800
-0.0500 (-5.38%)
At close: Oct 29, 2025, 4:00 PM EDT
0.8800
0.00 (0.00%)
After-hours: Oct 29, 2025, 4:10 PM EDT
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $10.03 million as of October 29, 2025. Its market cap has decreased by -76.93% in one year.
Market Cap
10.03M
Enterprise Value
18.83M
1-Year Change
-76.93%
Ranking
Category
Stock Price
$0.88
Market Cap Chart
Since April 12, 2021, AEON Biopharma's market cap has decreased from $63.66M to $10.03M, a decrease of -84.24%. That is a compound annual growth rate of -33.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 10.83M | -49.83% |
| Dec 31, 2024 | 21.58M | -91.93% |
| Dec 29, 2023 | 267.55M | -80.82% |
| Dec 30, 2022 | 1.40B | 553.24% |
| Dec 30, 2021 | 213.58M | 235.51% |
| Apr 12, 2021 | 63.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.04B |
| Johnson & Johnson | 457.77B |
| AbbVie | 402.76B |
| UnitedHealth Group | 328.31B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 220.78B |